ESSA Pharma News

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 15 05:52

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 14 23:29

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 14 22:54

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 14 22:05

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 12 05:01

ESSA Pharma | 8-K: ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024

Feb 11 20:06

ESSA Pharma | 10-Q: Q1 2025 Earnings Report

Feb 11 20:01

ESSA Pharma | DEFA14A: Others

Jan 23 05:21

ESSA Pharma | DEF 14A: Definitive information statements

Jan 23 05:17

ESSA Pharma | 8-K: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024

Dec 17, 2024 20:08

ESSA Pharma | 10-K: FY2024 Annual Report

Dec 17, 2024 20:03

ESSA Pharma | 8-K: Current report

Dec 16, 2024 19:12

ESSA Pharma | 8-K: Current report

Dec 6, 2024 20:04

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(0.0%),Biotech Growth N.V. N/A(0.0%)

Nov 15, 2024 08:37

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFM Health Sciences, LP(6.2%),PFM Health Sciences GP, LLC(6.2%), etc.

Nov 15, 2024 06:23

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(7.4%),Roderick Wong, M.D.(7.4%)

Nov 14, 2024 20:02

ESSA Pharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL MANAGEMENT, LLC(9.7%),KEVIN TANG(9.7%), etc.

Nov 9, 2024 06:00

ESSA Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BML Investment Partners, L.P.(9.4%)

Nov 8, 2024 01:54

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner BIOTECH GROWTH N V

Nov 6, 2024 01:11

ESSA Pharma | 8-K: Current report

Nov 2, 2024 04:33